SNWV (SANUWAVE Health) Float Percentage Of Total Shares Outstanding: 66.35% (As of Jul. 06, 2026)


SNWV SANUWAVE Health Inc SNWV
38 GF Score
Price $10.50
GF Value $11.96
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is SANUWAVE Health Float Percentage Of Total Shares Outstanding?

SANUWAVE Health SNWV -1.22% 38 Float Percentage Of Total Shares Outstanding is 66.35% as of Jul. 06, 2026. GuruFocus rates SNWV with a GF Score™ of 38/100 and a GF Value™ of $11.96 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SANUWAVE Health's float shares is 5.71 Mil. SANUWAVE Health's total shares outstanding is 8.60 Mil. SANUWAVE Health's float percentage of total shares outstanding is 66.35%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SANUWAVE Health's Insider Ownership is 27.65%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SANUWAVE Health's Institutional Ownership is 53.56%.

SNWV
38GF Score
SANUWAVE Health Inc SNWV
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SANUWAVE Health Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

SANUWAVE Health's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.71/8.60
=66.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 66.35% mean?
SANUWAVE Health (SNWV) has a Float Percentage Of Total Shares Outstanding of 66.35% as of Jul. 06, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on SANUWAVE Health and its competitors.
Is SANUWAVE Health's Float Percentage Of Total Shares Outstanding too high?
SANUWAVE Health's current Float Percentage Of Total Shares Outstanding is 66.35%. Overall, SANUWAVE Health has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Float Percentage Of Total Shares Outstanding compare to RTGN and NNOX?
SANUWAVE Health's Float Percentage Of Total Shares Outstanding of 66.35% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on SANUWAVE Health and its competitors. SANUWAVE Health's current Float Percentage Of Total Shares Outstanding is 66.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.96, compared to a current price of $10.50 — trading 12.2% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 66.35%. SANUWAVE Health's overall GF Score™ is 38/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Float Percentage Of Total Shares Outstanding is 66.35% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $10.50 is trading 12.2% below its estimated GF Value™ of $11.96. GuruFocus considers SANUWAVE Health to be Modestly Undervalued.

Key valuation signals for SNWV:

  • Float Percentage Of Total Shares Outstanding: 66.35%
  • GF Value™: $11.96 vs. price of $10.50 (12.2% below fair value)
  • GF Score™: 38/100 with 8 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SANUWAVE Health Business Description

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
38GF Score

Get the complete analysis for SNWV

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.50
Price
$11.96
GF Value